Qube Research & Technologies Ltd

Position in ALDX — Aldeyra Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in ALDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,404,350

+$2,257,189 QoQ

Shares Held

1,128,803

+1196.3% QoQ

Ownership

1.87%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 108 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. ALDX ranks #99 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,404,350	1,128,803	+1196.3%	Shares	Sole	2026-08-14
2026-03-31	$147,161	87,078	+2.5%	Shares	Sole	2026-05-15
2025-12-31	$439,927	84,928	+443.4%	Shares	Sole	2026-02-17
2023-12-31	$54,857	15,629	-80.1%	Shares	Sole	2024-02-13
2023-03-31	$780,061	78,556	+38.3%	Shares	Sole	2023-05-15
2022-12-31	$395,460	56,819	+59.0%	Shares	Sole	2023-02-14
2022-09-30	$190,787	35,728	+84.0%	Shares	Sole	2022-11-14
2022-06-30	$77,465	19,415	-55.3%	Shares	Sole	2022-08-15
2021-09-30	$381,570	43,459	-10.4%	Shares	Sole	2021-11-12
2021-06-30	$549,482	48,498	-15.7%	Shares	Sole	2021-08-13
2021-03-31	$683,123	57,502	-62.2%	Shares	Sole	2021-05-14
2020-12-31	$1,044,016	152,189	+246.8%	Shares	Sole	2021-02-16
2020-09-30	$325,195	43,886	+112.7%	Shares	Sole	2020-11-12
2020-06-30	$86,027	20,630	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.